[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and Infants

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this study is to:
• Test the safety and tolerability of 4 different formulations of the research study vaccine, V114.
• Test the immune system response to the study vaccine, V114.

Upstate Institutional Review Board (IRB) Number:

784386

Study/Protocol ID:

V114-005-00

Study Phase:

Phase I-II

Patient Age Group:

Children

Principal Investigator:

Leonard B Weiner

Who can I contact for more information?

Name: Kristen Fluno
Phone: 315-464-6331
Email: [email protected]

Return to Previous Page || Search Again

Top